Mobile Health Technology for Colorectal Cancer Recovery

Overseen by Heather Yeo, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Weill Medical College of Cornell University

No Placebo Group

Trial Summary

What is the purpose of this trial?

This is a randomized clinical trial to evaluate the use of mobile devices in preventing readmission in patients undergoing major GI cancer operations.

Research Team

Heather Yeo, MD

Principal Investigator

Weill Medical College of Cornell University

Eligibility Criteria

This trial is for English-speaking adults over 18 who own a smartphone and are scheduled for GI cancer surgery (pancreatic, liver, stomach, small bowel, colon or rectal). It's not suitable for those with dementia, substance abuse issues, sepsis from another source or needing emergency surgery.

Inclusion Criteria

I am scheduled for surgery for a GI cancer.

I speak English.

I am 18 years old or older.

Exclusion Criteria

My doctor says I can't finish the study because of my dementia.

I am currently suffering from sepsis caused by another condition.

I am scheduled for urgent surgery.

Treatment Details

Interventions

• Mobile health application and Fitbit (Mobile Health Application and Wearable Device)
• Standard of care (Other)

Trial Overview The study compares the effectiveness of using mobile health apps and Fitbit alongside standard care versus standard care alone in preventing hospital readmission after major GI cancer surgeries.

Participant Groups

Group I: Standard of care Experimental Treatment 1 Intervention

Participants will receive standard of care

Group II: Mobile app and Fitbit + Standard of care Active Control 1 Intervention

Mobile health application and Fitbit + standard of care: Participants will utilize mobile app and Fitbit and standard of care. Mobility data will be generated using a mobile health tracker designed for smartphone devices.

Who Is Running the Clinical Trial?

Weill Medical College of Cornell University

Lead Sponsor

Trials

1,103

Recruited

1,157,000+

Dr. Robert Min

Weill Medical College of Cornell University

Chief Executive Officer since 2024

MD, MBA

Dr. Adam R. Stracher

Weill Medical College of Cornell University

Chief Medical Officer since 2024

MD

Damon Runyon Cancer Research Foundation

Collaborator

Trials

10

Recruited

1,100+